Top compounds associated with response to FRG2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.099 0.05
mRNA hyperforin CTRPv2 pan-cancer AAC 0.073 0.06
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.087 0.07
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC -0.19 0.07
mRNA VX-680 CTRPv2 pan-cancer AAC -0.18 0.07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.07
mRNA lapatinib gCSI pan-cancer AAC -0.095 0.07
mRNA GDC-0941 gCSI pan-cancer AAC -0.1 0.07
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
Download CSV